Key points are not available for this paper at this time.
Figure S6. KRAS mutated tumors have an increased CD cytotoxicity score, which is lost with STK11 co-mutation
Principe et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: